Overview
Lijuan Feng practices practicing medicine in Chengdu, China.
Their clinical expertise encompasses Marginal Zone Lymphoma (MZL), IgA Nephropathy, Desmoid Tumor, and Glomerulonephritis.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lijuan Feng
Is Lijuan Feng a top-rated expert for Marginal Zone Lymphoma (MZL)?
MediFind is an objective health platform that identifies experts based on real-world data. Lijuan Feng is classified as an Experienced expert for Marginal Zone Lymphoma (MZL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lijuan Feng participate in research or clinical trials?
Yes. Lijuan Feng has published 16 articles and abstracts on conditions like Marginal Zone Lymphoma (MZL). You can view a list of Lijuan Feng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Desmoid TumorFeng isExperienced. Learn about Desmoid Tumor.
- FibromatosisFeng isExperienced. Learn about Fibromatosis.
- GlomerulonephritisFeng isExperienced. Learn about Glomerulonephritis.
- IgA NephropathyFeng isExperienced. Learn about IgA Nephropathy.
- Marginal Zone Lymphoma (MZL)